Skip to main content
Top
Published in: Endocrine 3/2009

01-06-2009 | Original Paper

Klotho suppresses TNF-α-induced expression of adhesion molecules in the endothelium and attenuates NF-κB activation

Authors: Yoshihiro Maekawa, Kazuhiko Ishikawa, Osamu Yasuda, Ryosuke Oguro, Hiroko Hanasaki, Iwao Kida, Yukihiro Takemura, Mitsuru Ohishi, Tomohiro Katsuya, Hiromi Rakugi

Published in: Endocrine | Issue 3/2009

Login to get access

Abstract

Klotho is a senescence suppressor protein that, when overexpressed, extends the lifespan of mice. Klotho-disrupted mice exhibit atherosclerosis and endothelial dysfunction, which led us to investigate the effect of the Klotho protein on vascular inflammation, particularly adhesion molecule expression. In this study, human umbilical vein endothelial cells (HUVECs) were preincubated with Klotho protein and then exposed to tumor necrosis factor-α (TNF-α) or vehicle. Reverse transcription-PCR and Western blot analyses revealed that Klotho suppressed TNF-α-induced expression of intracellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1). NF-κB activation, IκB phosphorylation induced by TNF-α were also attenuated by Klotho protein administration. The inhibition of eNOS phosphorylation by TNF-α was reversed by Klotho. Furthermore, Klotho inhibited TNF-α-induced monocyte adhesion to HUVECs and suppressed adhesion molecule expression in an organ culture of the rat aorta. These results suggest that Klotho suppresses TNF-α-induced expression of adhesion molecules and NF-κB activation. Klotho may have a role in the modulation of endothelial inflammation.
Literature
1.
go back to reference M. Kuro-o, Y. Matsumura, H. Aizawa, H. Kawaguchi, T. Suga, T. Utsugi, Y. Ohyama, M. Kurabayashi, T. Kaname, E. Kume, H. Iwasaki, A. Iida, T. Shiraki-Iida, S. Nishikawa, R. Nagai, Y.I. Nabeshima, Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature 390, 45–51 (1997)CrossRefPubMed M. Kuro-o, Y. Matsumura, H. Aizawa, H. Kawaguchi, T. Suga, T. Utsugi, Y. Ohyama, M. Kurabayashi, T. Kaname, E. Kume, H. Iwasaki, A. Iida, T. Shiraki-Iida, S. Nishikawa, R. Nagai, Y.I. Nabeshima, Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature 390, 45–51 (1997)CrossRefPubMed
2.
3.
go back to reference H. Kurosu, M. Yamamoto, J.D. Clark, J.V. Pastor, A. Nandi, P. Gurnani, O.P. McGuinness, H. Chikuda, M. Yamaguchi, H. Kawaguchi, I. Shimomura, Y. Takayama, J. Herz, C.R. Kahn, K.P. Rosenblatt, M. Kuro-o, Suppression of aging in mice by the hormone Klotho. Science 309, 1829–1833 (2005)CrossRefPubMed H. Kurosu, M. Yamamoto, J.D. Clark, J.V. Pastor, A. Nandi, P. Gurnani, O.P. McGuinness, H. Chikuda, M. Yamaguchi, H. Kawaguchi, I. Shimomura, Y. Takayama, J. Herz, C.R. Kahn, K.P. Rosenblatt, M. Kuro-o, Suppression of aging in mice by the hormone Klotho. Science 309, 1829–1833 (2005)CrossRefPubMed
4.
go back to reference N. Koh, T. Fujimori, S. Nishiguchi, A. Tamori, S. Shiomi, T. Nakatani, K. Sugimura, T. Kishimoto, S. Kinoshita, T. Kuroki, Y. Nabeshima, Severely reduced production of klotho in human chronic renal failure kidney. Biochem. Biophys. Res. Commun. 280, 1015–1020 (2001)CrossRefPubMed N. Koh, T. Fujimori, S. Nishiguchi, A. Tamori, S. Shiomi, T. Nakatani, K. Sugimura, T. Kishimoto, S. Kinoshita, T. Kuroki, Y. Nabeshima, Severely reduced production of klotho in human chronic renal failure kidney. Biochem. Biophys. Res. Commun. 280, 1015–1020 (2001)CrossRefPubMed
5.
go back to reference A. Kamitani, H. Yamada, M. Kinuta, M. Watanabe, S.A. Li, T. Matsukawa, M. McNiven, H. Kumon, K. Takei, Distribution of dynamins in testis and their possible relation to spermatogenesis. Biochem. Biophys. Res. Commun. 294, 261–267 (2002)CrossRefPubMed A. Kamitani, H. Yamada, M. Kinuta, M. Watanabe, S.A. Li, T. Matsukawa, M. McNiven, H. Kumon, K. Takei, Distribution of dynamins in testis and their possible relation to spermatogenesis. Biochem. Biophys. Res. Commun. 294, 261–267 (2002)CrossRefPubMed
6.
go back to reference K. Miyamoto, M. Ito, H. Segawa, M. Kuwahata, Molecular targets of hyperphosphataemia in chronic renal failure. Nephrol Dial Transplant 18(Suppl 3), iii79–iii80 (2003)PubMed K. Miyamoto, M. Ito, H. Segawa, M. Kuwahata, Molecular targets of hyperphosphataemia in chronic renal failure. Nephrol Dial Transplant 18(Suppl 3), iii79–iii80 (2003)PubMed
7.
go back to reference M. Yamamoto, J.D. Clark, J.V. Pastor, P. Gurnani, A. Nandi, H. Kurosu, M. Miyoshi, Y. Ogawa, D.H. Castrillon, K.P. Rosenblatt, M. Kuro-o, Regulation of oxidative stress by the anti-aging hormone klotho. J. Biol. Chem. 280, 38029–38034 (2005)CrossRefPubMed M. Yamamoto, J.D. Clark, J.V. Pastor, P. Gurnani, A. Nandi, H. Kurosu, M. Miyoshi, Y. Ogawa, D.H. Castrillon, K.P. Rosenblatt, M. Kuro-o, Regulation of oxidative stress by the anti-aging hormone klotho. J. Biol. Chem. 280, 38029–38034 (2005)CrossRefPubMed
8.
go back to reference H. Rakugi, N. Matsukawa, K. Ishikawa, J. Yang, M. Imai, M. Ikushima, Y. Maekawa, I. Kida, J. Miyazaki, T. Ogihara, Anti-oxidative effect of Klotho on endothelial cells through cAMP activation. Endocrine 31, 82–87 (2007)CrossRefPubMed H. Rakugi, N. Matsukawa, K. Ishikawa, J. Yang, M. Imai, M. Ikushima, Y. Maekawa, I. Kida, J. Miyazaki, T. Ogihara, Anti-oxidative effect of Klotho on endothelial cells through cAMP activation. Endocrine 31, 82–87 (2007)CrossRefPubMed
9.
go back to reference M. Ikushima, H. Rakugi, K. Ishikawa, Y. Maekawa, K. Yamamoto, J. Ohta, Y. Chihara, I. Kida, T. Ogihara, Anti-apoptotic and anti-senescence effects of Klotho on vascular endothelial cells. Biochem. Biophys. Res. Commun. 339, 827–832 (2006)CrossRefPubMed M. Ikushima, H. Rakugi, K. Ishikawa, Y. Maekawa, K. Yamamoto, J. Ohta, Y. Chihara, I. Kida, T. Ogihara, Anti-apoptotic and anti-senescence effects of Klotho on vascular endothelial cells. Biochem. Biophys. Res. Commun. 339, 827–832 (2006)CrossRefPubMed
10.
go back to reference H. Kurosu, Y. Ogawa, M. Miyoshi, M. Yamamoto, A. Nandi, K.P. Rosenblatt, M.G. Baum, S. Schiavi, M.C. Hu, O.W. Moe, M. Kuro-o, Regulation of fibroblast growth factor-23 signaling by klotho. J. Biol. Chem. 281, 6120–6123 (2006)CrossRefPubMed H. Kurosu, Y. Ogawa, M. Miyoshi, M. Yamamoto, A. Nandi, K.P. Rosenblatt, M.G. Baum, S. Schiavi, M.C. Hu, O.W. Moe, M. Kuro-o, Regulation of fibroblast growth factor-23 signaling by klotho. J. Biol. Chem. 281, 6120–6123 (2006)CrossRefPubMed
11.
go back to reference I. Urakawa, Y. Yamazaki, T. Shimada, K. Iijima, H. Hasegawa, K. Okawa, T. Fujita, S. Fukumoto, T. Yamashita, Klotho converts canonical FGF receptor into a specific receptor for FGF23. Nature 444, 770–774 (2006)CrossRefPubMed I. Urakawa, Y. Yamazaki, T. Shimada, K. Iijima, H. Hasegawa, K. Okawa, T. Fujita, S. Fukumoto, T. Yamashita, Klotho converts canonical FGF receptor into a specific receptor for FGF23. Nature 444, 770–774 (2006)CrossRefPubMed
12.
go back to reference T. Trepels, A.M. Zeiher, S. Fichtlscherer, The endothelium and inflammation. Endothelium 13, 423–429 (2006)CrossRefPubMed T. Trepels, A.M. Zeiher, S. Fichtlscherer, The endothelium and inflammation. Endothelium 13, 423–429 (2006)CrossRefPubMed
13.
go back to reference K. Larsson, Aspects on pathophysiological mechanisms in COPD. J. Intern. Med. 262, 311–340 (2007)CrossRefPubMed K. Larsson, Aspects on pathophysiological mechanisms in COPD. J. Intern. Med. 262, 311–340 (2007)CrossRefPubMed
14.
go back to reference Y. Saito, T. Yamagishi, T. Nakamura, Y. Ohyama, H. Aizawa, T. Suga, Y. Matsumura, H. Masuda, M. Kurabayashi, M. Kuro-o, Y. Nabeshima, R. Nagai, Klotho protein protects against endothelial dysfunction. Biochem. Biophys. Res. Commun. 248, 324–329 (1998)CrossRefPubMed Y. Saito, T. Yamagishi, T. Nakamura, Y. Ohyama, H. Aizawa, T. Suga, Y. Matsumura, H. Masuda, M. Kurabayashi, M. Kuro-o, Y. Nabeshima, R. Nagai, Klotho protein protects against endothelial dysfunction. Biochem. Biophys. Res. Commun. 248, 324–329 (1998)CrossRefPubMed
15.
go back to reference Y. Saito, T. Nakamura, Y. Ohyama, T. Suzuki, A. Iida, T. Shiraki-Iida, M. Kuro-o, Y. Nabeshima, M. Kurabayashi, R. Nagai, In vivo klotho gene delivery protects against endothelial dysfunction in multiple risk factor syndrome. Biochem. Biophys. Res. Commun. 276, 767–772 (2000)CrossRefPubMed Y. Saito, T. Nakamura, Y. Ohyama, T. Suzuki, A. Iida, T. Shiraki-Iida, M. Kuro-o, Y. Nabeshima, M. Kurabayashi, R. Nagai, In vivo klotho gene delivery protects against endothelial dysfunction in multiple risk factor syndrome. Biochem. Biophys. Res. Commun. 276, 767–772 (2000)CrossRefPubMed
16.
go back to reference D.G. Harrison, Cellular and molecular mechanisms of endothelial cell dysfunction. J. Clin. Invest. 100, 2153–2157 (1997)CrossRefPubMed D.G. Harrison, Cellular and molecular mechanisms of endothelial cell dysfunction. J. Clin. Invest. 100, 2153–2157 (1997)CrossRefPubMed
17.
go back to reference E. Galkina, K. Ley, Vascular adhesion molecules in atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 27, 2292–2301 (2007)CrossRefPubMed E. Galkina, K. Ley, Vascular adhesion molecules in atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 27, 2292–2301 (2007)CrossRefPubMed
18.
go back to reference R. Nagai, Y. Saito, Y. Ohyama, H. Aizawa, T. Suga, T. Nakamura, M. Kurabayashi, M. Kuroo, Endothelial dysfunction in the klotho mouse and downregulation of klotho gene expression in various animal models of vascular and metabolic diseases. Cell. Mol. Life Sci. 57, 738–746 (2000)CrossRefPubMed R. Nagai, Y. Saito, Y. Ohyama, H. Aizawa, T. Suga, T. Nakamura, M. Kurabayashi, M. Kuroo, Endothelial dysfunction in the klotho mouse and downregulation of klotho gene expression in various animal models of vascular and metabolic diseases. Cell. Mol. Life Sci. 57, 738–746 (2000)CrossRefPubMed
19.
go back to reference E. Jimi, S. Ghosh, Role of nuclear factor-kappaB in the immune system and bone. Immunol. Rev. 208, 80–87 (2005)CrossRefPubMed E. Jimi, S. Ghosh, Role of nuclear factor-kappaB in the immune system and bone. Immunol. Rev. 208, 80–87 (2005)CrossRefPubMed
20.
go back to reference J.M. Witkowski, M. Soroczynska-Cybula, E. Bryl, Z. Smolenska, A. Jozwik, Klotho—a common link in physiological and rheumatoid arthritis-related aging of human CD4+ lymphocytes. J. Immunol. 178, 771–777 (2007)PubMed J.M. Witkowski, M. Soroczynska-Cybula, E. Bryl, Z. Smolenska, A. Jozwik, Klotho—a common link in physiological and rheumatoid arthritis-related aging of human CD4+ lymphocytes. J. Immunol. 178, 771–777 (2007)PubMed
21.
go back to reference M.L. Handel, L.B. McMorrow, E.M. Gravallese, Nuclear factor-kappa B in rheumatoid synovium. Localization of p50 and p65. Arthritis Rheum. 38, 1762–1770 (1995)CrossRefPubMed M.L. Handel, L.B. McMorrow, E.M. Gravallese, Nuclear factor-kappa B in rheumatoid synovium. Localization of p50 and p65. Arthritis Rheum. 38, 1762–1770 (1995)CrossRefPubMed
22.
go back to reference Y. Kato, E. Arakawa, S. Kinoshita, A. Shirai, A. Furuya, K. Yamano, K. Nakamura, A. Iida, H. Anazawa, N. Koh, A. Iwano, A. Imura, T. Fujimori, M. Kuro-o, N. Hanai, K. Takeshige, Y. Nabeshima, Establishment of the anti-Klotho monoclonal antibodies and detection of Klotho protein in kidneys. Biochem. Biophys. Res. Commun. 267, 597–602 (2000)CrossRefPubMed Y. Kato, E. Arakawa, S. Kinoshita, A. Shirai, A. Furuya, K. Yamano, K. Nakamura, A. Iida, H. Anazawa, N. Koh, A. Iwano, A. Imura, T. Fujimori, M. Kuro-o, N. Hanai, K. Takeshige, Y. Nabeshima, Establishment of the anti-Klotho monoclonal antibodies and detection of Klotho protein in kidneys. Biochem. Biophys. Res. Commun. 267, 597–602 (2000)CrossRefPubMed
23.
go back to reference J. Yang, N. Matsukawa, H. Rakugi, M. Imai, I. Kida, M. Nagai, J. Ohta, K. Fukuo, Y. Nabeshima, T. Ogihara, Upregulation of cAMP is a new functional signal pathway of Klotho in endothelial cells. Biochem. Biophys. Res. Commun. 301, 424–429 (2003)CrossRefPubMed J. Yang, N. Matsukawa, H. Rakugi, M. Imai, I. Kida, M. Nagai, J. Ohta, K. Fukuo, Y. Nabeshima, T. Ogihara, Upregulation of cAMP is a new functional signal pathway of Klotho in endothelial cells. Biochem. Biophys. Res. Commun. 301, 424–429 (2003)CrossRefPubMed
24.
go back to reference M. Imai, K. Ishikawa, N. Matsukawa, I. Kida, J. Ohta, M. Ikushima, Y. Chihara, X. Rui, H. Rakugi, T. Ogihara, Klotho protein activates the PKC pathway in the kidney and testis and suppresses 25-hydroxyvitamin D3 1alpha-hydroxylase gene expression. Endocrine 25, 229–234 (2004)CrossRefPubMed M. Imai, K. Ishikawa, N. Matsukawa, I. Kida, J. Ohta, M. Ikushima, Y. Chihara, X. Rui, H. Rakugi, T. Ogihara, Klotho protein activates the PKC pathway in the kidney and testis and suppresses 25-hydroxyvitamin D3 1alpha-hydroxylase gene expression. Endocrine 25, 229–234 (2004)CrossRefPubMed
25.
go back to reference M.I. Cybulsky, M.A. Gimbrone Jr., Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science 251, 788–791 (1991)CrossRefPubMed M.I. Cybulsky, M.A. Gimbrone Jr., Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science 251, 788–791 (1991)CrossRefPubMed
26.
go back to reference A. Giatromanolaki, M.I. Koukourakis, D. Theodossiou, K. Barbatis, K. O’Byrne, A.L. Harris, K.C. Gatter, Comparative evaluation of angiogenesis assessment with anti-factor-VIII and anti-CD31 immunostaining in non-small cell lung cancer. Clin. Cancer Res. 3, 2485–2492 (1997)PubMed A. Giatromanolaki, M.I. Koukourakis, D. Theodossiou, K. Barbatis, K. O’Byrne, A.L. Harris, K.C. Gatter, Comparative evaluation of angiogenesis assessment with anti-factor-VIII and anti-CD31 immunostaining in non-small cell lung cancer. Clin. Cancer Res. 3, 2485–2492 (1997)PubMed
Metadata
Title
Klotho suppresses TNF-α-induced expression of adhesion molecules in the endothelium and attenuates NF-κB activation
Authors
Yoshihiro Maekawa
Kazuhiko Ishikawa
Osamu Yasuda
Ryosuke Oguro
Hiroko Hanasaki
Iwao Kida
Yukihiro Takemura
Mitsuru Ohishi
Tomohiro Katsuya
Hiromi Rakugi
Publication date
01-06-2009
Publisher
Springer US
Published in
Endocrine / Issue 3/2009
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-009-9181-3

Other articles of this Issue 3/2009

Endocrine 3/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.